Mersana Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MRSN and other ETFs, options, and stocks.About MRSN
Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of antibody-drug conjugates that offer clinical benefit for cancer patients. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592.
CEOMartin H. Huber
CEOMartin H. Huber
Employees123
Employees123
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2001
Founded2001
Employees123
Employees123
MRSN Key Statistics
Market cap349.35M
Market cap349.35M
Price-Earnings ratio-1.92
Price-Earnings ratio-1.92
Dividend yield—
Dividend yield—
Average volume1.84M
Average volume1.84M
High today$2.89
High today$2.89
Low today$2.88
Low today$2.88
Open price$3.21
Open price$3.21
Volume2.03K
Volume2.03K
52 Week high$9.62
52 Week high$9.62
52 Week low$0.8014
52 Week low$0.8014
MRSN News
Simply Wall St 3h
Investors Don't See Light At End Of Mersana Therapeutics, Inc.'s Tunnel And Push Stock Down 33%Mersana Therapeutics, Inc. ( ) shares have had a horrible month, losing 33% after a relatively good period beforehand. Instead of being rewarded, shareholders w...
Simply Wall St 5d
Shareholders in Mersana Therapeutics have lost 80%, as stock drops 15% this past week - Simply Wall StMersana Therapeutics, Inc. ( ) shareholders should be happy to see the share price up 20% in the last quarter. But that is meagre solace in the face of the shoc...
Analyst ratings
78%
of 9 ratingsBuy
77.8%
Hold
22.2%
Sell
0%